Patient Tolerability and Efficacy of Bowel Preparation With Split Dose Picosalax vs. Split Dose PEG

NCT02070341 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
5
Enrollment
OTHER
Sponsor class

Stopped Significant changes to protocol and study design, study stopped to further enrollment and new study designed.

Conditions

Interventions

Sponsor

Queen's University